A significant advance in cancer investigation is occurring with the use of VHH fragments to reactivate mutated p53. This essential tumor protector protein is frequently lost in various types of malignancies, leading https://bookmarkunit.com/story21793272/mini-antibodies-reactivate-p53-the-potential-hope-for-cancer-therapy